Split-hand index for the diagnosis of amyotrophic lateral sclerosis

Clinical Neurophysiology

Volumn 124, Issue 2, 2013, Pages 410-416

  Menon, Parvathi ^a,b   Kiernan, Matthew C ^c,d   Yiannikas, Con ^e,f   Stroud, Jill ^e   Vucic, Steve ^a,b,d  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^e Burwest Neurophysiology Laboratory   (Australia)

^f Department of Geriatric Medicine   (Australia)

Author keywords

ADM; AHC; ALS; APB; CMAP; FDI; LMN; MEP; MRC; Novel diagnostic index; ROC; SCA; SEM; SI; SMA; Split hand index; STARD; TMS; UMN

Indexed keywords

ABDUCTOR DIGITI MINIMI MUSCLE; ABDUCTOR POLLICIS BREVIS MUSCLE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DORSAL INTEROSSEOUS MUSCLE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MUSCLE; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPLIT HAND INDEX;

ACTION POTENTIALS; ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCULAR ATROPHY; NEUROMUSCULAR DISEASES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84872391237     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2012.07.025     Document Type: Article

References (33)

1. Aggarwal S., Cudkowicz M. ALS drug development: reflections from the past and a way forward. Neurotherapeutics 2008, 5:516-527.
2. Askanas V., Wojcik S., Engel W.K. Expression of Nogo-A in human muscle fibers is not specific for amyotrophic lateral sclerosis. Ann Neurol 2007, 62:676-677.
3. Bensimon G., Lacomblez L., Delumeau J.C., Bejuit R., Truffinet P., Meininger V. A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis. J Neurol 2002, 249:609-615.
4. Boekestein W.A., Kleine B.U., Hageman G., Schelhaas H.J., Zwarts M.J. Sensitivity and specificity of the 'Awaji' electrodiagnostic criteria for amyotrophic lateral sclerosis: retrospective comparison of the Awaji and revised El Escorial criteria for ALS. Amyotroph Lateral Scler 2010, 11:497-501.
5. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2000, 1:293-299.
6. Cedarbaum J.M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (Phase III). J Neurol Sci 1999, 169:13-21.
7. Chio A. ISIS survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. J Neurol 1999, 246(Suppl. 3):III1-III5.
8. De Carvalho M., Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 2000, 23:344-352.
9. de Carvalho M., Dengler R., Eisen A., England J.D., Kaji R., Kimura J., et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008, 119:497-503.
10. de Carvalho M., Swash M. Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph Lateral Scler 2009, 10:53-57.
11. Douglass C.P., Kandler R.H., Shaw P.J., McDermott C.J. An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry 2010, 81:646-649.
12. Eisen A., Kuwabara S. The split hand syndrome in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2012, 83:399-403.
13. Jokic N., Gonzalez de Aguilar J.L., Pradat P.F., Dupuis L., Echaniz-Laguna A., Muller A., et al. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann Neurol 2005, 57:553-556.
14. Kanai K., Kuwabara S., Misawa S., Tamura N., Ogawara K., Nakata M., et al. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 2006, 129:953-962.
15. Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., et al. Amyotrophic lateral sclerosis. Lancet 2011, 377:942-955.
16. Kimura F., Fujimura C., Ishida S., Nakajima H., Furutama D., Uehara H., et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006, 66:265-267.
17. Kuwabara S., Sonoo M., Komori T., Shimizu T., Hirashima F., Inaba A., et al. Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificity. Muscle Nerve 2008, 37:426-430.
18. Lehky T.J., Chen C.J., di Prospero N.A., Rhodes L.E., Fischbeck K., Floeter M.K. Standard and modified statistical MUNE evaluations in spinal-bulbar muscular atrophy. Muscle Nerve 2009, 40:809-814.
19. Lemon R.N., Griffiths J. Comparing the function of the corticospinal system in different species: organizational differences for motor specialization?. Muscle Nerve 2005, 32:261-279.
20. Menon P., Kiernan M.C., Vucic S. Appearance, phenomenology and diagnostic utility of the split hand in amyotrophic lateral sclerosis. Neurodegen Dis Manag 2011, 1:457-462.
21. Moore D.H., Katz J.S., Miller R.G. A review of clinical trial designs in amyotrophic lateral sclerosis. Neurodegen Dis Manag 2011, 1:481-490.
22. Noto Y.I., Misawa S., Kanai K., Shibuya K., Isose S., Nasu S., et al. Awaji ALS criteria increase the diagnostic sensitivity in patients with bulbar onset. Clin Neurophysiol 2012, 123:382-385.
23. O'Brien M.D. Aid to the examination of the peripheral nervous system 2010, Saunders, Edinburgh, p. 2. 5th ed.
24. Rutkove S.B., Shefner J.M., Gregas M., Butler H., Caracciolo J., Lin C., et al. Characterizing spinal muscular atrophy with electrical impedance myography. Muscle Nerve 2010, 42:915-921.
25. Rutkove S.B., Zhang H., Schoenfeld D.A., Raynor E.M., Shefner J.M., Cudkowicz M.E., et al. Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials. Clin Neurophysiol 2007, 118:2413-2418.
26. Schrooten M., Smetcoren C., Robberecht W., Van Damme P. Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study. Ann Neurol 2011, 70:79-83.
27. Swash M. Early diagnosis of ALS/MND. J Neurol Sci 1998, 160(Suppl. 1):S33-S36.
28. Traynor B.J., Codd M.B., Corr B., Forde C., Frost E., Hardiman O.M. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and airlie house diagnostic criteria: a population-based study. Arch Neurol 2000, 57:1171-1176.
29. Turner M.R., Kiernan M.C., Leigh P.N., Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 2009, 8:94-109.
30. Vucic S., Burke D., Kiernan M.C. Diagnosis of motor neuron disease. The motor neuron disease handbook 2007, 89-115. Australasian Medical Publishing Company Limited, Sydney. M.C. Kiernan (Ed.).
31. Vucic S., Kiernan M.C. Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol 2006, 117:1458-1466.
32. Weber M., Eisen A., Stewart H., Hirota N. The split hand in ALS has a cortical basis. J Neurol Sci 2000, 180:66-70.
33. Wilbourn A.J. The " split hand syndrome" Muscle Nerve 2000, 23:138.